Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 100

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 100
---
)183.8 5.1 349.1 57.0 Proxy contest charges (4)0.3 0.1 — — Other tax only discrete items— (0.2)— (0.5)Total discrete items208.5 10.8 359.0 58.9 Consolidated operations, before discrete items$65.8 $14.6 $24.4 $8.0 EAETR (5)22.2 %33.5 %Six Months Ended June 30,20252024In millions, except percentagesBefore taxTaxEffective tax rate % impactBefore taxTaxEffective tax rate % impactConsolidated operations$(115.9)$10.1 (8.7)%$(406.5)$(66.8)16.4 %Discrete items:Restructuring and other (income) charges, net (1)34.2 8.1 74.8 17.5 (Gain) loss on strategic investments (2)2.5 0.6 4.7 1.1 Goodwill impairment (3)183.8 5.1 349.1 57.0 Proxy contest charges (4)8.2 1.9 — — Other tax only discrete items— (0.6)— (1.4)Total discrete items228.7 15.1 428.6 74.2 Consolidated operations, before discrete items$112.8 $25.2 $22.1 $7.4 EAETR (5)22.3 %34.5 %_______________(1) See Note 11 for further information. For the three and six months ended June 30, 2024, the charge includes zero and $2.5 million of lower of cost or market charges associated with the Performance Chemicals repositioning. Amounts are included in "Cost of sales" on the condensed consolidated statements of operations.(2) See Note 4 for further information. (3) See Note 7 for further information. (4) See Note 14 for further information. (5) Decrease in EAETR for the three and six months ended June 30, 2025, as compared to June 30, 2024, primarily reflects a shift in the projected mix of earnings across